Literature DB >> 7619359

Serum 25-hydroxycholecalciferol concentration in newly detected hypertension.

R Scragg1, I Holdaway, V Singh, P Metcalf, J Baker, E Dryson.   

Abstract

Although blood concentrations of the active metabolite 1,25-dihydroxyvitamin D are raised in hypertension, concentrations of 25-hydroxyvitamin D, the main vitamin D metabolite, do not appear to have been reported in newly detected hypertension. Serum levels of 25-hydroxycholecalciferol were measured in 186 newly detected hypertensive patients (blood pressure > 160/95 mm Hg and never on antihypertensive medication) and normotensive controls individually matched by sex, age (+/- 2 years), ethnicity, and date of interview. Serum 25-hydroxycholecalciferol levels were similar in cases (mean (SD) = 64 (21) nmol/L) and controls (67 (28) nmol/L, P = .20). We conclude that serum 25-hydroxycholecalciferol, a marker of body vitamin D, is normal in hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619359     DOI: 10.1016/0895-7061(94)00195-h

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

Review 1.  Vitamin d therapy and cardiovascular health.

Authors:  Suzanne E Judd; Vin Tangpricha
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

2.  Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals.

Authors:  S Cottone; L Guarino; R Arsena; C Scazzone; F Tornese; M Guarneri; C Guglielmo; A Bono; G Mulè
Journal:  J Hum Hypertens       Date:  2014-12-11       Impact factor: 3.012

Review 3.  Vitamin D status and arterial hypertension: a systematic review.

Authors:  Stefan Pilz; Andreas Tomaschitz; Eberhard Ritz; Thomas R Pieber
Journal:  Nat Rev Cardiol       Date:  2009-08-18       Impact factor: 32.419

4.  A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men.

Authors:  Lu Wang; Jing Ma; Joann E Manson; Julie E Buring; J Michael Gaziano; Howard D Sesso
Journal:  Eur J Nutr       Date:  2012-12-21       Impact factor: 5.614

5.  Association of calcium concentration with pulse pressure in older women: data from a large population-based multicentric study.

Authors:  L Mateus-Hamdan; O Beauchet; Y Rolland; A-M Schott; C Annweiler
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

6.  25-hydroxyvitamin D levels and hypertension rates.

Authors:  Simran K Bhandari; Shahe Pashayan; In Lu A Liu; Scott A Rasgon; Dean A Kujubu; Thomas Y Tom; John J Sim
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-22       Impact factor: 3.738

7.  Serum 25-hydroxyvitamin D3, parathyroid hormone and blood pressure in an elderly cohort from Germany: a cross-sectional study.

Authors:  Alexandra Jungert; Heinz J Roth; Monika Neuhäuser-Berthold
Journal:  Nutr Metab (Lond)       Date:  2012-03-21       Impact factor: 4.169

8.  Association between vitamin D and hypertension in people coming for health check up to a tertiary care centre in South India.

Authors:  Rose Mary J Vatakencherry; L Saraswathy
Journal:  J Family Med Prim Care       Date:  2019-06

9.  Role of vitamin d in cardiometabolic diseases.

Authors:  Chaoxun Wang
Journal:  J Diabetes Res       Date:  2013-02-25       Impact factor: 4.011

10.  Omega-3 Fatty acids and vitamin d in cardiology.

Authors:  Norbert Güttler; Kirila Zheleva; Mariana Parahuleva; Ridvan Chasan; Mehmet Bilgin; Christiane Neuhof; Mehmet Burgazli; Bernd Niemann; Ali Erdogan; Andreas Böning
Journal:  Cardiol Res Pract       Date:  2012-12-31       Impact factor: 1.866

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.